Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate

被引：28
作者：
Rousselot, P [1 ]
Larghero, J
Raffoux, E
Calvo, F
Tulliez, M
Giraudier, S
Rybojad, M
机构：
[1] Hop St Louis, Serv Clin Malad Sang, Paris, France
[2] Hop St Louis, Ctr Invest Clin, Paris, France
[3] Hop Henri Mondor, Hematol Lab, F-94010 Creteil, France
[4] Hop St Louis, Serv Dermatol, F-75475 Paris, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2003年 / 120卷 / 06期
关键词：
imatinib mesylate; c-Kit; chronic myelogenous leukaemia; photosensitivity; depigmentation;
D O I：
10.1046/j.1365-2141.2003.04208_3.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1091 / 1092
页数：2
相关论文
共 6 条
[1]   Cutaneous reactions to STI571 [J].
Brouard, M ;
Saurat, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (08) :618-619
[2]   Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. [J].
Kantarjian, H ;
Sawyers, C ;
Hochhaus, A ;
Guilhot, F ;
Schiffer, C ;
Gambacorti-Passerini, C ;
Niederwieser, D ;
Resta, D ;
Capdeville, R ;
Zoellner, U ;
Talpaz, M ;
Druker, B .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :645-652
[3]   Challenges in oncology - Case 3. Depigmentation in a chronic myeloid leukemia patient treated with STI-571 [J].
Raanani, P ;
Goldman, JM ;
Ben-Bassat, I .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :869-870
[4]   A novel KIT mutation results in piebaldism with progressive depigmentation [J].
Richards, KA ;
Fukai, K ;
Oiso, N ;
Paller, AS .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (02) :288-292
[5]   Drug therapy: Imatinib mesylate - A new oral targeted therapy. [J].
Savage, DG ;
Antman, KH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (09) :683-693
[6]  
VALEYRIE L, 2003, IN PRESS J AM ACAD D
1